Literature DB >> 21838176

[Histopathology and etiopathogenesis of chronic apical periodontitis--periapical granuloma].

J Kovác1, D Kovác.   

Abstract

Periapical lesions are among the most frequently diagnosed apical odontogenic pathologies in human teeth. The condition is generally described as apical periodontitis. Apical periodontitis is a sequel to endodontic infection and manifests itself as the host defense response to microbial challenge emanating from the root canal system to the periapical tissue. It is viewed as a dynamic encounter between microbial factors and host defenses at the interface between infected radicular pulp and periodontal ligament that results in local inflammation, resorption of hard tissues, destruction of other periapical tissues, and eventual formation of various histopathological categories of apical periodontitis, commonly referred to as periapical lesions. There are also factors located within the inflamed periapical tissue that can interfere with post-treatment healing of the lesion. The purpose of this article is to provide a comprehensive overview of the etiopathogenesis of apical periodontitis and causes of failed endodontic treatment. This study presents a histopathological analysis through optical microscopy of periapical lesions, commonly referred to as solid dental or periapical granuloma.

Entities:  

Mesh:

Year:  2011        PMID: 21838176

Source DB:  PubMed          Journal:  Epidemiol Mikrobiol Imunol        ISSN: 1210-7913            Impact factor:   0.444


  1 in total

1.  Effect of non-steroidal anti-inflammatory drugs on pulpal and periapical inflammation induced by lipopolysaccharide.

Authors:  Fernanda Regina Ribeiro-Santos; Maya Fernanda Manfrin Arnez; Marcio Santos de Carvalho; Raquel Assed Bezerra da Silva; Marília Pacífico Lucisano Politi; Alexandra Mussolino de Queiroz; Paulo Nelson-Filho; Léa Assed Bezerra da Silva; Lúcia Helena Faccioli; Francisco Wanderley Garcia Paula-Silva
Journal:  Clin Oral Investig       Date:  2021-04-01       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.